Cadence Raises $100M to Expand Chronic Care — Impact on RCM Teams
Digital health startup Cadence has reportedly raised $100 million to enhance its chronic disease management program, bringing its valuation to approximately $1.23 billion. This funding will be directed towards automating care processes using regulated AI, positioning Cadence as a significant player in the digital health landscape.The Deal
Cadence's recent funding round raised $100 million, with participation from prominent investors. The company is now valued at around $1.23 billion. Details regarding the closing date of this funding round have not been publicly disclosed.What It Means for RCM
- Increased efficiency in chronic disease management could lead to lower denial rates for claims related to these patients.
- Automation may streamline workflows, reducing days in accounts receivable and improving cash flow for healthcare providers.
- The use of regulated AI could enhance patient outcomes, ultimately driving higher reimbursement rates as value-based care models gain traction.
Market Context
The funding environment for healthcare RCM continues to be robust, with increasing investments in technologies that leverage AI to improve operational efficiencies. This trend reflects a broader shift towards integrating advanced technology in chronic disease management, as organizations seek innovative solutions to address the complexities of patient care. As Cadence moves forward with its ambitious plans, other players in the RCM space will need to adapt to this evolving landscape or risk being left behind.Free Daily RCM Intelligence
Denial trends, payer policy moves, vendor intel — delivered every morning. Free.